EP2844233
ORAL TABLET FORMULATION CONSISTING OF FIXED COMBINATION OF ROSUVASTATIN AND EZETIMIBE FOR TREATMENT OF HYPERLIPIDEMIA AND CARDIOVASCULAR DISEASES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
1.5.2013EP published:
6.5.2020EP application number:
13785009.5
EPO information:
European Patent Register
Max expiry date:
30.4.2033
Title:
ORAL TABLET FORMULATION CONSISTING OF FIXED COMBINATION OF ROSUVASTATIN AND EZETIMIBE FOR TREATMENT OF HYPERLIPIDEMIA AND CARDIOVASCULAR DISEASES
Timeline
Today
1.5.2013EP application
6.5.2020EP Publication
Owner
Name:
Althera Life Sciences, LLCAddress:
1448 89 Headquarters Plaza, Morristown, NJ 07960, US
Inventor
Name:
DIAS, Marie, CharmaineAddress:
Morristown, NJ 07960, US
Priority
Number:
201261641013 PDate:
1.5.2012Country:
US
Classification
Categories:
A61K 9/24, A61K 31/505, A61K 31/397